Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-12-28

Clinical Trial Update: Study of Laser Treatment of Melasma [NA]

View source ↗

Summary

Clinical trial of laser treatment for refractory mixed-type melasma has been completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Laser treatment (unspecified device)

Snippet

Sponsor: ConBio, a Cynosure Company | Conditions: Refractory Mixed Type Melasma | NA | Status: COMPLETED | Results posted: 2020-12-28